- KERX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $34.4 million.
- KERX has traded 90,347 shares today.
- KERX is down 3.3% today.
- KERX was up 14.8% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in KERX with the Ticky from Trade-Ideas. See the FREE profile for KERX NOW at Trade-Ideas More details on KERX: Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Currently there are 9 analysts that rate Keryx Biopharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Keryx Biopharmaceuticals has been 1.7 million shares per day over the past 30 days. Keryx has a market cap of $1.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 5.19 and a short float of 37.8% with 10.08 days to cover. Shares are down 34.1% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.